Dr. Anil Batta
My Social Links

Dr. Anil Batta

Professor
Panjab University, Chandigarh, india

Highest Degree
Ph.D. in Pharmacology from Punjabi University, Patiala, India

Share this Profile

Biography

Dr. Anil Batta is currently working as Professor of Medical Biochemistry. His main area of interest related to Medical Biochemistry. His main area of expertise includes Carcinoma, Enzyme, Gut, Drugs, Myocardial Infarction, Hepatitis, Addiction, Cirrhosis, Heart, Liver, Deaddiction, Prostate, and Cardiac. He has published 23 articles in journals. He is associate member to Editorial Board International Journal of Biological and Medical Research, and appointed as Editor-in-Chief of International Journal: Americas Journal of Biochemistry. He also appointed as Session Chair of 1st International World Scientific E-Conference for Tumor Markers and De-addiction, to be held by Texila American University, Guyana, South America, STIE Perbanas.

Area of Interest:

Pharmacology and Toxicology
100%
Biochemistry
62%
Enzymology
90%
Pharmacological Analysis
75%
Genetics
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
127
Abstracts
0

Selected Publications

  1. Batta. A., 2014. Treatment of gout -A new approach. IOSR J. Dent. Med. Sci., 13: 60-64.
  2. Batta. A., 2014. Smoking disrupts lipid profil. Int. J. Innovative Res. Dev., 3: 43-47.
  3. Batta. A., 2014. Sensitive troponins overpower complex cpk�mb. Int. J. Biol. Med. Res., 5: 3897-3900.
  4. Batta. A., 2014. Biochemical approach to diagnose myocardial infarction. Int. J. Biol. Med. Res., 5: 3901-3907.
  5. Batta A.K., 2014. Depression follows myocardial infarction. Int. J. Biol. Med. Res., 5: 3893-3896.
  6. Batta. A., 2012. Diagnosis of carcinoma breast --- role of biomarkers. Int. J. Curr. Biomed. Pharm. Res.,2 2: 277-281.
  7. Batta. A., 2012. Cardiac markers-- role in diagnosis of myocardial infarction. Int. J. Curr. Bio. Med. Sci., 2: 262-267.
  8. Batta. A., 2012. Cardiac markers diagnosis of prostate cancer---role of biomarkers. Int. J. Curr. Biomed. Pharm. Res., 2: 340-346.
  9. Batta. A., 2012. Carcinoma lung---major updates in biomarkers for early diagnosis. Int. J. Biol. Med. Res., 3: 1974-1981.
  10. Kumar, P., H. Kalonia and A. Kumar, 2011. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: A comparative study. J. Psychopharmacol., 25: 1399-1411.
    CrossRef  |  PubMed  |  Direct Link  |  
  11. Kalonia, H., P. Kumar and A. Kumar, 2011. Licofelone attenuates quinolinic acid induced Huntington like symptoms: Possible behavioral, biochemical and cellular alterations. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 35: 607-615.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Kalonia, H., P. Kumar and A. Kumar, 2011. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. Behav. Brain Res., 216: 220-228.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Kalonia, H., P. Kumar and A. Kumar, 2011. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Res., 1372: 115-126.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Gaur, V. and A. Kumar, 2011. Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. Inflammopharmacology, 19: 205-214.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Batta. A., 2011. Viral hepatitis and enzyme study. Int. J. Cur Biomed. Pharm. Res., 1: 11-14.
  16. Batta. A., 2011. Thin layer chromatography----a cost effective & accurate method to detect abuse drugs in third world countries (medical professionals). Int. J. Curr. Biol. Med. Sci., 1: 82-85.
  17. Batta. A., 2011. The effects of hyperthyroidism on lipid peroxidation, erythrocyte glutathione and glutathione peroxidase. Int. J. Curr. Biol. Med. Sci., 1: 127-129.
  18. Batta. A., 2011. Smoking - A potential suicidal. Int. J. Chem. Res., 1: 39-45.
  19. Batta. A., 2011. Metabolic syndrome�relationship of CAD (coronary artery disease) diabetes�type-2 LDL cholesterol & C-- Reactive protein. Int. J. Curr. Sci. Res., 1: 234-237.
  20. Batta. A., 2011. Hepatic malignancy-A challenge for early diagnosis. Int. J. Curr. Biol. Med. Sci., 1: 126-130.
  21. Batta. A., 2011. Dextropropoxyphene - A drug to be used judicially. Int. J. Chem. Res., 1: 34-38.
  22. Batta. A., 2011. Detection of addiction in medical professionals�an eye opener. Int. J. Cur Biomed. Pharm. Res., 2: 796-799.
  23. Batta. A., 2011. Comparative study of serum 5� NT, ALP, AST, ALT and bilirubin in hepatobiliary diseases. Int. J. Cur Biomed. Pharm. Res., 1: 93-97.
  24. Batta. A., 2011. Addiction in adolescents�a current trend. J. Biosci. Tech., 2: 258-261.
  25. Batta. A. and K.M.D.S. Panag, 2011. Alcohol dependence, womanizing & treatment with disulfiram study. Int. J. Cur Biomed. Pharm. Res., 1: 122-123.
  26. Anil. B., 2011. Comparative study of 5� NT, ALP, AST, ALT, bilirubin in alcoholic liver disease. Int. J. Biol. Med. Res., 2: 439-442.
  27. Anil. B. and K.M.D.S. Panag, 2011. Cholecystitis and enzyme study. Int. J. Biol. Med. Res., 1: 11-14.
  28. Anil. B. and K.M.D.S. Panag, 2011. Alcohol dependence, womanizing & treatment with disulfiram study. Int. J. Biol. Med. Res., 1: 122-123.
  29. Kumar, P., H. Kalonia, A. Kumar and A. Goyal, 2010. 3-nitropropionic acid-induced neurotoxicity as an experimental model of Huntington`s disease: Possible behavioral, biochemical and cellular alterations. J. Pharm. Educ. Res., 2: 26-36.
    Direct Link  |  
  30. Kumar, P., H. Kalonia and A. Kumar, 2010. Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. Drug Chem. Toxicol., 33: 377-392.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Kumar, P., H. Kalonia and A. Kumar, 2010. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease. Behav. Pharmacol., 21: 217-230.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Kumar, P., H. Kalonia and A. Kumar, 2010. Cyclosporine A attenuates 3-nitropropionic acid-induced huntington-like symptoms in rats: Possible nitric oxide mechanism. Int. J. Toxicol., 29: 318-325.
    CrossRef  |  Direct Link  |  
  33. Kumar, P. and A. Kumar, 2010. Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats. Basic Clin. Pharmacol. Toxicol., 107: 577-582.
    CrossRef  |  PubMed  |  Direct Link  |  
  34. Kumar, P. and A. Kumar, 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide. Behav. Brain Res., 206: 38-46.
    CrossRef  |  PubMed  |  Direct Link  |  
  35. Kumar, A., S. Dogra and A. Prakash, 2010. Protective effect of naringin, a citrus flavonoid, against colchicine induced cognitive dysfunction and oxidative damage in rats. J. Med. Food, 13: 976-984.
    CrossRef  |  PubMed  |  Direct Link  |  
  36. Kumar, A., R. Garg, V. Gaur and P. Kumar, 2010. Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. Brain Res., 1311: 73-80.
    CrossRef  |  PubMed  |  Direct Link  |  
  37. Kumar, A., R. Garg, V. Gaur and P. Kumar, 2010. Possible role of NO modulators in protective effect of trazodone and citalopram (antidepressants) in acute immobilization stress in mice. Indian J. Exp. Biol., 48: 1131-1135.
    PubMed  |  
  38. Kumar, A., R. Garg and A.K. Prakash, 2010. Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice. BMC Complemen. Altern. Med., 10: 18-18.
    CrossRef  |  PubMed  |  Direct Link  |  
  39. Kumar, A., B. Kumari and P. Kumar, 2010. Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress. Neurosci. Bull., 26: 17-27.
    CrossRef  |  PubMed  |  Direct Link  |  
  40. Kumar, A., A. Vashist and P. Kumar, 2010. Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice. Inflammopharmacology, 18: 241-251.
    CrossRef  |  PubMed  |  Direct Link  |  
  41. Kumar, A., A. Prakash and S. Dogra, 2010. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by d-galactose in mice. Food Chem. Toxicol., 48: 626-632.
    CrossRef  |  PubMed  |  Direct Link  |  
  42. Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2010. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats. NeuroToxicology, 31: 195-203.
    CrossRef  |  PubMed  |  Direct Link  |  
  43. Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2010. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats. Neuroscience, 171: 284-299.
    CrossRef  |  PubMed  |  Direct Link  |  
  44. Kalonia, H., P. Kumar and A. Kumar, 2010. Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats. Eur. J. Pharmacol., 634: 46-52.
    CrossRef  |  PubMed  |  Direct Link  |  
  45. Kalonia, H., P. Kumar and A. Kumar, 2010. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Υ (PPARΥ) in Huntington disease. Pharmacol. Biochem. Behav., 96: 115-124.
    CrossRef  |  PubMed  |  Direct Link  |  
  46. Gupta, A., A. Kumar and S.K. Kulkarni, 2010. Licofelone attenuates MPTP-induced neuronal toxicity: Behavioral, biochemical and cellular evidence. Inflammopharmacology, 18: 223-232.
    CrossRef  |  PubMed  |  Direct Link  |  
  47. Gupta, A., A. Dhir, A. Kumar and S.K. Kulkarni, 2010. Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: Behavioral, biochemical and histological evidences. Indian J. Exp. Biol., 48: 577-585.
    PubMed  |  Direct Link  |  
  48. Gaur, V. and A. Kumar, 2010. Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: Possible involvement of NO-cGMP pathway. Brain Res., 1353: 204-212.
    CrossRef  |  PubMed  |  Direct Link  |  
  49. Gaur, V. and A. Kumar, 2010. Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: Possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway. Brain Res. Bull., 82: 57-64.
    CrossRef  |  PubMed  |  Direct Link  |  
  50. Bali, A., K. Sharma, A. Bhalla, S. Bala, D. Reddy, A. Singh and A. Kumar, 2010. Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics. Eur. J. Med. Chem., 45: 2656-2662.
    CrossRef  |  PubMed  |  Direct Link  |  
  51. Aggarwal, A., V. Gaur and A. Kumar, 2010. Nitric oxide mechanism in the protective effect of naringin against Post-Stroke Depression (PSD) in mice. Life Sci., 86: 928-935.
    CrossRef  |  PubMed  |  Direct Link  |  
  52. Prakash, A.K. and A. Kumar, 2009. Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats. J. Pharm. Pharmacol., 61: 1665-1672.
    CrossRef  |  PubMed  |  Direct Link  |  
  53. Prakash, A. and A. Kumar, 2009. Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin. Pharmacol. Toxicol., 105: 98-104.
    CrossRef  |  PubMed  |  Direct Link  |  
  54. Kumar, P., H. Kalonia and A. Kumar, 2009. Sesamol attenuate 3-nitropropionic acid-induced huntington like behavioral, biochemical and cellular alterations in rats. J. Asian Nat. Prod. Res., 11: 439-450.
    CrossRef  |  PubMed  |  Direct Link  |  
  55. Kumar, P., H. Kalonia and A. Kumar, 2009. Lycopene modulate nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci., 85: 711-718.
    CrossRef  |  PubMed  |  Direct Link  |  
  56. Kumar, P. and A. Kumar, 2009. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain. Indian J. Exp. Biol., 47: 715-722.
    PubMed  |  Direct Link  |  
  57. Kumar, P. and A. Kumar, 2009. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: Possible nitric oxide mechanisms. Psychopharmacology, 207: 257-270.
    CrossRef  |  PubMed  |  Direct Link  |  
  58. Kumar, P. and A. Kumar, 2009. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington`s disease like symptoms: Possible behavioural, biochemical and cellular alterations. Eur. J. Pharmacol., 615: 91-101.
    CrossRef  |  PubMed  |  Direct Link  |  
  59. Kumar, P. and A. Kumar, 2009. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J. Med. Food, 12: 591-600.
    CrossRef  |  PubMed  |  Direct Link  |  
  60. Kumar, P. and A. Kumar, 2009. Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: Possible role of nitric oxide. Neurosci. Res, 63: 302-314.
    CrossRef  |  PubMed  |  Direct Link  |  
  61. Kumar, P. and A. Kumar, 2009. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism. Food Chem. Toxicol., 47: 2522-2530.
    CrossRef  |  PubMed  |  Direct Link  |  
  62. Kumar, A., S. Dogra and A. Prakash, 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav. Brain Res., 205: 384-390.
    CrossRef  |  PubMed  |  Direct Link  |  
  63. Kumar, A., S. Dogra and A. Prakash, 2009. Neuroprotective effects of Centella asiatica against Intracerebroventricular colchicine-induced cognitive impairment and oxidative stress. Int. J. Alzheimers Dis., 2009: 1-8.
    CrossRef  |  PubMed  |  Direct Link  |  
  64. Kumar, A., S. Dogra and A. Prakash, 2009. Effect of carvedilol on behavioral, mitochondrial dysfunction and oxidative damage against D-galactose induced senescence in mice. Naunyn-Schmiedeberg`s Arch. Pharmacol., 380: 431-441.
    CrossRef  |  PubMed  |  Direct Link  |  
  65. Kumar, A., R. Garg, V. Gaur and P. Kumar, 2009. Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. Neurosci. Lett., 467: 72-75.
    CrossRef  |  PubMed  |  Direct Link  |  
  66. Kumar, A. and R. Garg, 2009. Possible role of trazodone and imipramine in sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Method Find. Clin. Pharmacol., 31: 383-387.
    PubMed  |  
  67. Kumar, A. and Beenta, 2009. Prescription writing trends of antihistamines at the university health centre. Indian J. Pharm. Sci., 71: 307-309.
    CrossRef  |  PubMed  |  Direct Link  |  
  68. Kumar, A. and A. Singh, 2009. Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation-induced behaviour modification and oxidative damage in mice. Fundam. Clin. Pharmacol., 23: 439-448.
    CrossRef  |  PubMed  |  Direct Link  |  
  69. Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2009. Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacology, 17: 211-219.
    CrossRef  |  PubMed  |  Direct Link  |  
  70. Gupta, A., A. Dhir, A. Kumar and S.K. Kulkarni, 2009. Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats. Pharmacol. Behav. Biochem., 94: 219-226.
    CrossRef  |  PubMed  |  Direct Link  |  
  71. Gaur, V., A. Aggarwal and A. Kumar, 2009. Protective effect of naringin against ischemic reperfusion cerebral injury: Possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur. J. Pharmacol., 616: 147-154.
    CrossRef  |  PubMed  |  Direct Link  |  
  72. Bali, A., M. Sarika, H. Dhir, A. Kumar and A. Sharma, 2009. Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical antipsychotic effect. Bioorg. Med. Chem. Lett., 19: 3041-3044.
    CrossRef  |  PubMed  |  Direct Link  |